Rigel 宣布将举行电话会议和网络直播，报告 2025 年第二季度的财务业绩和业务更新 | RIGL 股票新闻
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) will report its Q2 2025 financial results on August 5, 2025, after market close. A live conference call and webcast will follow at 4:30 p.m. ET to discuss the results and provide a business update. Participants can join by calling 877-407-3088 (domestic) or 201-389-0927 (international). The webcast will be available for replay for 90 days. Rigel focuses on developing therapies for hematologic disorders and cancer.
, /PRNewswire/ -- Rigel Pharmaceuticals,Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2025 financial results after market close on Tuesday, August 5, 2025.Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international).The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com.The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visitwww.rigel.com.
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email:david.rosen@argotpartners.com
SOURCE Rigel Pharmaceuticals, Inc.
